Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
SYK logo SYK
Upturn stock ratingUpturn stock rating
SYK logo

Stryker Corporation (SYK)

Upturn stock ratingUpturn stock rating
$389.67
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: SYK (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

32 Analysts rated it

Highly popular stock, broad analyst coverage, trusted insights, strong investor interest.

1 Year Target Price $432.27

1 Year Target Price $432.27

Analysts Price Target For last 52 week
$432.27 Target price
52w Low $328.46
Current$389.67
52w High $404.87

Analysis of Past Performance

Type Stock
Historic Profit -7.08%
Avg. Invested days 40
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 148.97B USD
Price to earnings Ratio 51.54
1Y Target Price 432.27
Price to earnings Ratio 51.54
1Y Target Price 432.27
Volume (30-day avg) 32
Beta 0.91
52 Weeks Range 328.46 - 404.87
Updated Date 08/29/2025
52 Weeks Range 328.46 - 404.87
Updated Date 08/29/2025
Dividends yield (FY) 0.84%
Basic EPS (TTM) 7.56

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-07-31
When After Market
Estimate 3.07
Actual 3.13

Profitability

Profit Margin 12.25%
Operating Margin (TTM) 21.95%

Management Effectiveness

Return on Assets (TTM) 7.74%
Return on Equity (TTM) 14.25%

Valuation

Trailing PE 51.54
Forward PE 29.33
Enterprise Value 163089684811
Price to Sales(TTM) 6.25
Enterprise Value 163089684811
Price to Sales(TTM) 6.25
Enterprise Value to Revenue 6.9
Enterprise Value to EBITDA 28.53
Shares Outstanding 382307008
Shares Floating 344604152
Shares Outstanding 382307008
Shares Floating 344604152
Percent Insiders 5.36
Percent Institutions 81.66

ai summary icon Upturn AI SWOT

Stryker Corporation

stock logo

Company Overview

overview logo History and Background

Stryker Corporation was founded in 1941 by Dr. Homer Stryker, an orthopedic surgeon. Initially focused on developing medical equipment to improve patient outcomes, Stryker has grown through innovation and acquisitions into a leading global medical technology company.

business area logo Core Business Areas

  • MedSurg and Neurotechnology: Offers products and equipment for surgical procedures, endoscopy, communications, and neurotechnology, including neurosurgical, neurovascular, and spinal devices.
  • Orthopaedics and Spine: Focuses on implants used in joint replacement, trauma, sports medicine, and spinal surgeries.

leadership logo Leadership and Structure

Kevin A. Lobo serves as the Chairman and CEO. The company operates with a divisional structure aligned with its core business segments, with each segment having its own leadership team reporting to corporate executives.

Top Products and Market Share

overview logo Key Offerings

  • Joint Replacement Implants: Implants for hip, knee, and shoulder replacements. Stryker is a major player in this market, competing with Zimmer Biomet (ZBH), Johnson & Johnson (JNJ), and Smith & Nephew (SNN). Market share data varies by region, but Stryker is consistently among the top three globally.
  • Surgical Navigation Systems: These systems provide real-time surgical guidance, improving accuracy and efficiency. Competitors include Medtronic (MDT) and Brainlab. Stryker's Q Guidance System has been driving growth in this segment.
  • Endoscopy Equipment: Visualization systems and related equipment used in minimally invasive surgery. Olympus and Karl Storz are key competitors in this market.

Market Dynamics

industry overview logo Industry Overview

The medical technology industry is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and technological advancements in surgical procedures and diagnostic tools.

Positioning

Stryker is positioned as a leader in the medical technology industry, known for its innovation, broad product portfolio, and strong brand reputation. Its competitive advantages include a robust R&D pipeline, a global sales network, and a history of successful acquisitions.

Total Addressable Market (TAM)

The global medical devices market is estimated at approximately $500 billion USD. Stryker is well-positioned to capture a significant portion of this market through its diverse product offerings and global reach.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Diverse product portfolio
  • Extensive global sales network
  • Robust R&D pipeline
  • History of successful acquisitions

Weaknesses

  • High product development costs
  • Exposure to healthcare regulatory changes
  • Dependence on third-party suppliers
  • Price pressure from competitors

Opportunities

  • Expanding into emerging markets
  • Developing new minimally invasive surgical technologies
  • Leveraging data analytics and AI for personalized medicine
  • Acquiring complementary businesses

Threats

  • Increased competition from existing players and new entrants
  • Changes in healthcare reimbursement policies
  • Product liability claims
  • Economic downturns affecting healthcare spending

Competitors and Market Share

competitor logo Key Competitors

  • ZBH
  • JNJ
  • MDT
  • BSX

Competitive Landscape

Stryker's advantages include its broad product portfolio, strong brand reputation, and extensive global sales network. Disadvantages may include high product development costs and exposure to healthcare regulatory changes.

Major Acquisitions

Vocera Communications

  • Year: 2022
  • Acquisition Price (USD millions): 3090
  • Strategic Rationale: To expand Stryker's digital capabilities and presence in the healthcare communication space.

Growth Trajectory and Initiatives

Historical Growth: Stryker has demonstrated consistent revenue and earnings growth over the past decade, driven by organic growth and strategic acquisitions.

Future Projections: Analysts project continued growth for Stryker, driven by its innovative product pipeline and expansion into new markets. Revenue growth is expected to be in the mid-single digits.

Recent Initiatives: Recent initiatives include investments in robotic surgery, digital health solutions, and expansion into emerging markets.

Summary

Stryker is a strong medical technology company with a diverse product portfolio and a history of consistent growth. Its innovative products and strategic acquisitions drive expansion, particularly in robotic surgery and digital health. Challenges include navigating healthcare regulations and managing high product development costs but the company has strong strengths that are able to combat them. Strong and consistent cash flow support investments and dividend payouts and provide security for all shareholders.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC Filings (10-K, 10-Q), Investor Relations, Market Research Reports, Analyst Reports

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It is not investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Stryker Corporation

Exchange NYSE
Headquaters Portage, MI, United States
IPO Launch date 1988-02-01
Chairman, CEO & President Mr. Kevin A. Lobo
Sector Healthcare
Industry Medical Devices
Full time employees 53000
Full time employees 53000

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.